Abstract
A series of early-passage cell lines were transformed with the v-Ki-ras oncogene with the aim of examining the effect of an activatedras gene on the ability of these cells to express major histocompatibility complex (MHC) antigens. These cell lines were found to undergo multiple phenotypic changes upon transformation and subsequent proliferation. At early passage, the predominant effect ofras was an increased ability to express class II antigens when induced with interferon γ (IFNγ). For class I antigens, maximum levels of expression induced with IFNγ were largely unaffected, however, decreased sensitivity to induction with this lymphokine was noted. With subsequent in vitro or in vivo passage, both class I and class II antigen inducibility was attenuated. The latter phenotypic change was found to be transferable by coculture, implicating a soluble IFNγ antagonist. Conditioned media fromras-transformed cells treated to activate their latent transforming growth factor β (TGFβ) content mediated similar changes in MHC antigen inducibility, suggesting that TGF\ may be involved in modulating MHC antigen expression inras-transformed cells.
Key words: ras, MHC, Transforming growth factor β
References
- 1.Albino AP, Houghton AN, Eisinger M, Lee JS, Kantor RR, Oliff Al, Old LJ. Class II histocompatibility antigen expression in human melanocytes transformed by Harvey murine sarcoma virus (Ha-MSV) and Kirsten MSV retroviruses. J Exp Med. 1986;164:1710. doi: 10.1084/jem.164.5.1710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Anzano MA, Roberts AB, De Lacrco JE, Wakefield LM, Assoian RK, Roche NS, Smith JM, Lazarus JE, Sporn MB. Increased secretion of type β transforming growth factor accompanies viral transformation of cells. Mol Cell Biol. 1985;5:242. doi: 10.1128/mcb.5.1.242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Barrett-Lee P, Travers M, Luqmani Y, Commbe S. Transcripts for transforming growth factor in human breast cancer: clinical correlates. Br J Cancer. 1990;61:612. doi: 10.1038/bjc.1990.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Bateman WJ, Fiera R, Matthews N, Morris AG. Inducibility of class II major histocompatibility complex antigens by interferongamma is associated with reduced tumorigenicity in C3H mouse cells transformed by v-Ki-rat . J Exp Med. 1991;173:193. doi: 10.1084/jem.173.1.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Benoist C, Mathis D. Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu Rev Immunol. 1990;8:681. doi: 10.1146/annurev.iy.08.040190.003341. [DOI] [PubMed] [Google Scholar]
- 6.Betterle C, Presotto F, Caretto A, Pelizzo MR, Pedini B, Girelli ME, Busnardo B. Expression of class I and II human leukocyte antigens by thyrocytes and lymphocytic infiltration on human thyroid tumors. Cancer. 1991;67:977. doi: 10.1002/1097-0142(19910215)67:4<977::aid-cncr2820670420>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
- 7.Bos JL. ras oncogenes in human cancer: a review. Cancer Res. 1989;49:4682. [PubMed] [Google Scholar]
- 8.Concha A, Esteban F, Cabrera T, Ruiz-Cabello F, Garrido F. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer. Semin Cancer Biol. 1991;2:47. [PubMed] [Google Scholar]
- 9.Czarniecki CW, Chiu HH, Wong GHW, Mc Cabe SM, Palladino MA. Transforming growth factor-β1 modulates the expression of class II histocompatibility antigens on human cells. J Immunol. 1988;140:4217. [PubMed] [Google Scholar]
- 10.Darley RL, Morris AG, Passas J, Bateman WJ. Interactions between interferon-gamma and retinoic acid with transforming growth factor-beta in the induction of immune recognition molecules. Cancer Immunol Immunother. 1993;37:112. doi: 10.1007/BF01517043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.David-Watine B, Israel A, Kourilsky P. The regulation and expression of MHC class I genes. Immunol Today. 1990;11:286. doi: 10.1016/0167-5699(90)90114-o. [DOI] [PubMed] [Google Scholar]
- 12.Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH. Synthesis of messenger RNAs for transforming growth factors alpha and tgb and the epidermal growth factor receptor by human tumors. Cancer Res. 1987;47:707. [PubMed] [Google Scholar]
- 13.Endo K, Borer CH, Tsujimoto Y. Modulation of LFA-1 surface antigen expression by activated H-ras oncogene in EBV-infected human lymphoblastoid cells. Oncogene. 1991;6:1391. [PubMed] [Google Scholar]
- 14.Gauthier-Rouviere C, Fernandez A, Lamb NJC. ras-induced c-fos expression and proliferation in living rat cells involve c-kinase activation and the trrum response element pathway. EMBO J. 1990;9:171. doi: 10.1002/j.1460-2075.1990.tb08093.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Geiser AG, Kim S-J, Roberts AB, Sporn MB. Characterization of the mouse transforming growth factor-β1 promoter and activation by the Ha-ras oncogene. Mol Cell Biol. 1991;11:84. doi: 10.1128/mcb.11.1.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Gomella LG, Sargent ER, Wade TP, Anglard P, Linehan WM, Kasid A. Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and β1 in renal cell carcinoma. Cancer Res. 1989;49:6972. [PubMed] [Google Scholar]
- 17.Hersey P, Jamal O. Innnunohistochemical relation between DR expression on melanoma cells and infittration by CD8+ cells. Pathology. 1990;22:133. doi: 10.3109/00313029009063551. [DOI] [PubMed] [Google Scholar]
- 18.Hilton D, West K. An evaluation of the prognostic singificance of HLA-DR expression in gastric carcinoma. Cancer. 1990;66:1154. doi: 10.1002/1097-0142(19900915)66:6<1154::aid-cncr2820660613>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
- 19.Huber D, Phillipp J, Fontana A. Protease inhibitors interfere with the transforming growth factor-β-dependent but not the transforming growth factor-β-independent pathway of tumor cell-mediated immunosuppression. J Immunol. 1992;148:277. [PubMed] [Google Scholar]
- 20.Hume CR, Accolla RS, Lee JS. Derective HLA class II expression in a regulatory mutant is partially complemented by activatedras oncogenes. Proc Natl Acad Sci USA. 1987;84:8603. doi: 10.1073/pnas.84.23.8603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Ito N, Kawata S, Tamura S, Takaishi K, Shirai Y, Kiso S, Yabuuchi I, Matsuda Y, Nishioka M, Tarui S. Elevated levels of transforming growth factor β messenger RNA and its polypeptide in human hepatocellular carcinoma. Cancer Res. 1991;51:4080. [PubMed] [Google Scholar]
- 22.Kushtai G, Feldman M, Eisenbach L. c-jos transfection of 3L1 tumour cells turns on MHC gene expression and consequently reduces their metastatic competence. Int J Cancer. 1990;45:1131. doi: 10.1002/ijc.2910450624. [DOI] [PubMed] [Google Scholar]
- 23.Lenardo M, Rustgi AK, Schievella AR, Bernards R. Suppression of MHC class I gene expression by N-myc through enhancer inactivation. EMBO J. 1989;8:3351. doi: 10.1002/j.1460-2075.1989.tb08497.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Lu Y-Y, Blair DG, Segal S, Shih TY, Clanton DJ. Tumorigenicity, metastasis and suppression of MHC class I expression in murine cells transformed by mutan v-ras deficient in GTP binding. Int J Cancer. 1991;6(Supp):45. doi: 10.1002/ijc.2910470712. [DOI] [PubMed] [Google Scholar]
- 25.Maudsley DJ, Morris AG. Kirsten murine sarcoma virus abolishes interferon gamma-induced class II but not class I major histocompatibility antigen expression in a murine cell line. J Exp Med. 1988;167:706. doi: 10.1084/jem.167.2.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Miller TP, Lippman SM, Spier CM, Slymen DJ, Grogan TM. HLA-DR (Ia] immune phenotype predicts outcome for patients with diffuse large cell lymphoma. J Clin Invest. 1988;82:370. doi: 10.1172/JCI113598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Moller P, Momburg F, Koretz K, Moldenhauer G, Herfarth C, Otto HF, Hämmerling GJ, Schlag P. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma. Cancer Res. 1991;51:729. [PubMed] [Google Scholar]
- 28.Morris AG, Ward GA. Production of recombinant interferons by expression in beterologous mammalian cells. In: Clemens MJ, Morris AG, Gearing AJH, editors. Lymphokines and interferons: a practical approach. Oxford, UK: IRL Press; 1988. p. 61. [Google Scholar]
- 29.Morris AG, Barrett AD, Bird RM, Burke DC. The effect of malignant transformation on the sensitivity of murine cells to the antiviral effect of interferon. FEMS Microbiol Lett. 1979;6:139. [Google Scholar]
- 30.Morris AG, Darley RL, Bateman WJ. The loss of class II MHC antigen expression byras-transformed murine cells passaged as tumours correlates with increased tumorigenicity but is not mediated by T cells. Cancer Immunol Immunother. 1992;35:46. doi: 10.1007/BF01741054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.O'Keane JC, Mack C, Lynch E, Harrington E, Neiman RS. Prognostic correlation of HLA-DR expression in large cell lymphoma as determined by LN3 antibody staining. Cancer. 1990;66:1147. doi: 10.1002/1097-0142(19900915)66:6<1147::aid-cncr2820660612>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
- 32.Politis AD, Vogel SN. Pharmacologic evidence for the requirement of protein kinase C in IFN-induced macrophage Fc receptor and la antigen expression. J Immunol. 1990;145:3788. [PubMed] [Google Scholar]
- 33.Ruiter DJ, Mattijssen V, Broecker E-B, Ferrone S. MHC antigens in human melanomas. Semin Cancer Biol. 1991;2:35. [PubMed] [Google Scholar]
- 34.Sato Y, Rifkin DB. Antocrine activities of basic cell growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol. 1988;107:1199. doi: 10.1083/jcb.107.3.1199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Theodorescu D, Bergsma D, Man MS, Elshourbagy N, Sheehan C, Rieman D, Kerbel RS. Cloning and overexpression of TGF-β1 cDNA in a mammary adenocarcinoma: in vitro and in vivo effects. Growth Factors. 1991;5:305. doi: 10.3109/08977199109000294. [DOI] [PubMed] [Google Scholar]
- 36.Todaro GJ, Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol. 1963;17:299. doi: 10.1083/jcb.17.2.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Versteeg R, Noordermeer IA, Kruse-Walters M, Ruiter D, Schrier PI. c-myc downregulates class I HLA expression in human melanomas. EMBO J. 1988;7:1023. doi: 10.1002/j.1460-2075.1988.tb02909.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Wakefield LM, Smith DM, Masui T, Harris CC, Sporn MB. Distribution and modulation of the cellular receptor for transforming growth factor-β. J Cell Biol. 1987;105:965. doi: 10.1083/jcb.105.2.965. [DOI] [PMC free article] [PubMed] [Google Scholar]
